These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 26043154

  • 21. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
    Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, Baba K, Ishibashi M, Hayabuchi N, Narula J, Imaizumi T.
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
    [Abstract] [Full Text] [Related]

  • 22. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P, Köhler J, Wittsack HJ, Heusner TA, Buchbender C, Poeppel TD, Nensa F, Wetter A, Gauler T, Hartung V, Lanzman RS.
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [Abstract] [Full Text] [Related]

  • 23. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
    Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T, Kurabayashi M.
    J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
    [Abstract] [Full Text] [Related]

  • 24. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
    Verburg FA, Kuhl CK, Pietsch H, Palmowski M, Mottaghy FM, Behrendt FF.
    Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The relevance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in diagnosing prosthetic graft infections post cardiac and proximal thoracic aortic surgery.
    Guenther SP, Cyran CC, Rominger A, Saam T, Kazmierzcak PM, Bagaev E, Pichlmaier M, Hagl C, Khaladj N.
    Interact Cardiovasc Thorac Surg; 2015 Oct; 21(4):450-8. PubMed ID: 26174118
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJW, Davies R, Hessian R, Liu P, Beanlands RSB, Nery PB.
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [Abstract] [Full Text] [Related]

  • 31. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
    Treglia G, Annunziata S, Sobic-Saranovic D, Bertagna F, Caldarella C, Giovanella L.
    Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
    [Abstract] [Full Text] [Related]

  • 32. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
    Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, Ohbayashi C, Sugimura K.
    J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
    [Abstract] [Full Text] [Related]

  • 33. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
    Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, Miura M, Sakaue S, Tamaki N, Nishimura M.
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
    [Abstract] [Full Text] [Related]

  • 34. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [Abstract] [Full Text] [Related]

  • 35. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K, Inubushi M, Wagatsuma K, Nagao M, Murata T, Koyama M, Koizumi M, Sasaki M.
    Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285
    [Abstract] [Full Text] [Related]

  • 36. 18F-FDG-PET/CT better localizes active spinal infection than MRI for successful minimally invasive surgery.
    Nakahara M, Ito M, Hattori N, Magota K, Takahata M, Nagahama K, Sudo H, Kamishima T, Tamaki N, Iwasaki N.
    Acta Radiol; 2015 Jul; 56(7):829-36. PubMed ID: 25080515
    [Abstract] [Full Text] [Related]

  • 37. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.
    Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, Govender P, Ruberg FL, Miller EJ.
    J Nucl Cardiol; 2014 Oct; 21(5):925-39. PubMed ID: 24879453
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Diagnostic values of delayed additional FDG PET/CT scan in the evaluation of cardiac sarcoidosis.
    Manabe O, Takahashi K, Kawakami H, Ohtsuka A, Aikawa T, Maki H, Ibe T, Fujita H, Oyama-Manabe N.
    Ann Nucl Med; 2023 Oct; 37(10):535-540. PubMed ID: 37418117
    [Abstract] [Full Text] [Related]

  • 40. The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.
    Cistaro A, Lopci E, Gastaldo L, Fania P, Brach Del Prever A, Fagioli F.
    Pediatr Blood Cancer; 2012 Dec 15; 59(7):1206-10. PubMed ID: 22745027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.